January 16, 2020 Bayer and WuXi Biologics enter into an agreement on a Leverkusen drug product plantRead more
January 13, 2020 Not intended for U.S. and UK MediaBayer and Daré Bioscience enter into exclusive license agreement for U.S. commercial rights to investigational hormone-free, monthly contraceptive Ovaprene®Read more
January 10, 2020 Bayer and Azitra partner to harness the human skin microbiome as a source for new natural skin care products for sensitive and eczema-prone skinRead more
January 9, 2020 Bayer and Exscientia collaborate to leverage the potential of artificial intelligence in cardiovascular and oncology drug discoveryRead more
January 9, 2020 Bayer and Evotec form new strategic alliance focusing on polycystic ovary syndromeRead more
January 7, 2020 Bayer exercises right to enter into follow-on research and collaboration option agreement with AtomwiseRead more
SPECIALIZED PRESS December 12, 2019 Bayer receives marketing authorization for Neptra® in EuropeRead more
November 29, 2019 Bayer completes sale of Currenta stake to Macquarie Infrastructure and Real AssetsRead more
